164 related articles for article (PubMed ID: 719637)
21. Proceedings: Local Corynebacterium parvum therapy in early breast cancer.
Ackroyd NW; Boak JL
Br J Surg; 1976 Aug; 63(8):659. PubMed ID: 953485
[No Abstract] [Full Text] [Related]
22. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. IX. Macrophage content of tumors in mice.
Gebhardt MC; Fisher B
J Natl Cancer Inst; 1979 Apr; 62(4):1035-41. PubMed ID: 285276
[No Abstract] [Full Text] [Related]
23. Chemoimmunotherapy (DTIC and Corynebacterium parvum) as adjuvant treatment in malignant melanoma.
Karakousis CP; Didolkar MS; Lopez R; Baffi R; Moore R; Holyoke ED
Cancer Treat Rep; 1979; 63(11-12):1739-43. PubMed ID: 393377
[TBL] [Abstract][Full Text] [Related]
24. Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities.
Greager JA; Baldwin RW
Cancer Res; 1978 Jan; 38(1):69-73. PubMed ID: 618584
[No Abstract] [Full Text] [Related]
25. Repression of lymphatic metastasis by a second implant of the same tumor.
Keller R
Invasion Metastasis; 1985; 5(5):295-308. PubMed ID: 4030246
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide.
Fisher B; Gebhardt M; Linta J; Saffer E
Cancer Res; 1978 Sep; 38(9):2679-87. PubMed ID: 679170
[No Abstract] [Full Text] [Related]
27. Lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with intratumor injection of killed Corynebacterium parvum.
Likhite VV; Halpern BN
Cancer Res; 1974 Feb; 34(2):341-4. PubMed ID: 4810906
[No Abstract] [Full Text] [Related]
28. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
Fisher B; Wolmark N; Coyle J
J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
[No Abstract] [Full Text] [Related]
29. Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma.
Neri A; Welch D; Kawaguchi T; Nicolson GL
J Natl Cancer Inst; 1982 Mar; 68(3):507-17. PubMed ID: 6950180
[TBL] [Abstract][Full Text] [Related]
30. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
Fisher B; Gebhardt M
Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
[TBL] [Abstract][Full Text] [Related]
31. Involvement of soybean agglutinin binding cells in the lymphatic metastasis of the R3230AC rat mammary adenocarcinoma.
Buckley ND; Carlsen SA
Cancer Res; 1988 Mar; 48(6):1451-5. PubMed ID: 3345516
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of tumor metastasis by a circulating suppressor factor.
Torosian MH; Bartlett DL
J Surg Res; 1993 Jul; 55(1):74-9. PubMed ID: 8412085
[TBL] [Abstract][Full Text] [Related]
33. Effect of C. parvum on intratumor immunity to the T1699 mammary adenocarcinoma.
Haskill S; Ritter F; Becker S
J Immunol; 1980 Jul; 125(1):454-8. PubMed ID: 6247400
[No Abstract] [Full Text] [Related]
34. Active experimental inhibition of cancer by corynebacterium parvum.
Wrba H; Dutter A
Osterr Z Onkol; 1977 Oct; 4(2-3):60-1. PubMed ID: 579449
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
Miyata H; Himeno K; Nomoto K
Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of Corynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma.
Pavelic ZP; Dave S; Bialkowski S; Priore RL; Greco WR
Cancer Res; 1980 Dec; 40(12):4617-21. PubMed ID: 7438095
[TBL] [Abstract][Full Text] [Related]
37. Rejection of tumors and metastases in Fischer 344 rats following intratumor administration of killed Corynebacterium parvum.
Likhite VV
Int J Cancer; 1974 Nov; 14(5):684-90. PubMed ID: 4459281
[No Abstract] [Full Text] [Related]
38. [Metastatic behavior of footpad-inoculated tumors in mice and the impact of OK-432 per os administration].
Nakajima Y; Akimoto M; Kimura M; Iwasaki H; Matano S; Hirakawa H; Mori S
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1229-33. PubMed ID: 3579323
[TBL] [Abstract][Full Text] [Related]
39. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
Lee YT
Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
[TBL] [Abstract][Full Text] [Related]
40. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
Likhite VV
J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
